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Purpose: The aim of this study was to evaluate perioperative complications of ro-
bot-assisted laparoscopic surgery in gynecology. Materials and Methods: Pa-
tients who underwent elective robot-assisted laparoscopic surgery between Febru-
ary 2006 and December 2013 were identified. Robotic procedures were performed 
using the da Vinci robotic system. Patient demographic data and operative out-
comes were prospectively collected in a computerized database and extracted for 
this study. Results: Two hundred and ninety eight patients were identified during 
the study period. One case was converted to conventional laparoscopy due to me-
chanical failure of the robot system before the procedure and excluded from re-
view. The median age and body mass index of patients were 48 years and 23.0 kg/
m2, respectively. The majority (n=130, 43.6%) of operative procedures was radical 
hysterectomy, followed by endometrial cancer staging (n=112, 37.6%), total hys-
terectomy (n=39, 13.1%), and myomectomy (n=17, 5.7%). The median operative 
time, estimated blood loss, and postoperative hospital stay were 208.5 min, 184.8 
mL, and 8.9 days, respectively. The overall complication rate was 18.8% and that 
for only oncologic cases was 16.1%. Intraoperative complications (n=5, 1.7%) 
consisted of three vessel injuries, one bowel content leakage during an appendec-
tomy during endometrial cancer staging and one case of bladder injury during rad-
ical hysterectomy. Early and late postoperative complications were 14.4% and 
2.7%, respectively. Five patients (1.7%) experienced grade 3 complications ac-
cording to Clavien-Dindo classification and therefore needed further intervention. 
Conclusion: Robot-assisted laparoscopic surgery is a feasible approach in gyne-
cology with acceptable complications.
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INTRODUCTION
Laparoscopic surgery offers significant postoperative advantages, including faster 
recovery time, improved cosmesis, shorter length of hospital stay, lower cost, and 
reduced pain, compared to laparotomy.1,2 However, conventional laparoscopy still 
has its drawbacks, such as limited mobility of laparoscopic instruments, two di-
mensional view, poor ergonomic position for the surgeon, and a steep learning 
curve. Robot-assisted laparoscopic surgery is considered an alternative approach 
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All procedures were performed by surgeons experienced 
and proficient in advanced laparoscopic gynecologic proce-
dures. The surgical team consisted of a chief resident or fel-
low as surgical assistants at the bedside or at the caudal part 
of the patient for uterine manipulation. A RUMI uterine 
manipulator equipped with a Koh colpotomy ring and a 
vaginal balloon pnuemo-occluder (Cooper Surgical Inc., 
Trumball, CT, USA) was routinely placed for adequate pel-
vic exposure, unless failure occurred due to a bulky cervi-
cal mass or cervical stenosis. All robotic surgeries were per-
formed using Maryland bipolar forceps on the left robotic 
arm and a permanent cautery spatula or needle holder on 
the right robotic arm. Total operative time was recorded as 
the time from the first skin incision to the last port site skin 
closure. Docking time was defined as the time to position 
the robotic column and install the robotic arms securely to 
the port sites. Console time was defined as the time the sur-
geon spent at the robotic console during the main proce-
dure. Ports were placed after creating pneumoperitoneum 
by Veress needle insertion or by an open Hasson method at 
the umbilicus. Four trocars with three robotic arms were 
used as a routine port placment: a 12-mm conventional lap-
aroscopic trocar at the umbilicus for the camera (2 cm up-
wards from the umbilicus for endometrial cancer staging); 
two 8-mm lateral robotic trocars at each lower quadrant of 
the abdomen at 2 to 3 cm below the umbilical level; and a 
fourth conventional trocar (either 5 or 10 mm) at the mid-
distance between the umbilicus and the left robotic arm for 
the bedside assistant. The bedside assistant assisted in pro-
cedures, such as suction, irrigation, retraction of tissues, and 
lymph node retrieval, through the 5 or 10 mm trocar placed 
on the left side of the patient. 
The surgical management of cervical cancer included radi-
cal hysterectomy with removal of bilateral pelvic lymph 
nodes, as described in our previous report.7 All pelvic lymph-
adenectomies were performed in a standard da Vinci system 
setup (robotic tower in between the patients’ legs in a steep 
Trendelenburg position). The decision to perform paraaortic 
lymph node dissection was made at the surgeon’s discretion. 
Modified radical or radical hysterectomy was performed ac-
cording to stage. For surgical staging in endometrial cancer, 
extended total hysterectomy with bilateral pelvic lymph node 
dissection, as well as routine paraaortic lymph node dissec-
tion, was performed. The vaginal cuff was closed either in-
tracorporeally using interrupted/continuous sutures of 1-Vic-
ryl (Ethicon, Piscataway, NJ, USA) or extracorporeally 
using a Clarke-Reich knot pusher. For myomectomy, the 
that addresses the current limitations of conventional lapa-
roscopic surgery. The robotic platform improves visualiza-
tion and allows for greater precision and a shorter learning 
curve in performing surgical tasks.3,4 Numerous reports 
have demonstrated the feasibility of robotic surgery in gy-
necology.5,6 Therefore, the use of robotic systems in mini-
mally invasive gynecologic surgeries has increased sub-
stantially over the past decade. 
Nevertheless, there are several shortcomings of robotic 
platforms, such as the absence of tactile feedback in the ro-
botic arms and the need for ports of larger diameter, com-
pared to conventional laparoscopy. These weaknesses might 
lead to increases in operative complications. Although a 
number of previous studies have addressed the complica-
tions of conventional laparoscopic approaches in gynecolo-
gy, only a few studies have reported on complications during 
robot-assisted laparoscopic procedures using a standardized 
tool.7-10 As well, most of the literature describes the compli-
cations of robotic surgery using four robotic arms and cate-
gorizes complications as either major or minor. Meanwhile, 
accurate assessment of the complication rates of robot-as-
sisted laparoscopic procedures may be challenging due to 
underestimation by reporting bias, incomplete data collec-
tion, and the lack of standardization in defining complica-
tions among institutions: unbiased reports of the risks associ-
ated with robotic surgery are important for training purposes, 
as well as for future development of advanced operative in-
struments and techniques. 
Accordingly, the purpose of this study was to identify the 
overall and specific complications associated with robot-as-
sisted laparoscopic gynecologic surgery using three robotic 
arms at a single high-volume institution.
MATERIALS AND METHODS
Between February 2006 and December 2013, patients who 
underwent robotic surgery at the Department of Obstetrics 
and Gynecology, Severance Hospital for gynecologic con-
ditions were identified. All robot-assisted surgery was per-
formed using the S or Si da Vinci system (Intuitive Surgi-
cal, Inc., Sunnyvale, CA, USA). Data pertaining to patient 
demographics, diagnosis, perioperative outcomes and com-
plications were prospectively collected in a computerized 
database. Data were retrieved from the database for a retro-
spective review. This study was approved by the Institution-
al Review Board of Yonsei University College of Medicine. 
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underwent a myomectomy, day two for those who under-
went a hysterectomy or endometrial cancer staging surgery, 
and on days 7 to 12 after radical hysterectomy. A hemovac 
drain was left in the pelvic cavity in case of a radical hyster-
ectomy and staging surgery, and removed around postoper-
ative day 5, according to the drainage amount. All patients 
were permitted sips of water beginning six hours after an 
inadvertent benign operation. A clear liquid diet was of-
fered as the first meal after passing flatus. The next meal 
consisted of soft foods, followed by a general diet. 
Complications were categorized as intraoperative and 
postoperative events. Postoperative complications were fur-
ther divided into early (less than postoperative 6 weeks) 
and late (after postoperative 6 weeks) events. Clavien-Din-
do classification was used to stratify complications into five 
grades according to their therapeutic interventions.11
Descriptive statistical analysis was performed with IBM 
SPSS software version 20 for Windows (SPSS Inc., Chica-
go, IL, USA). Kolmogorov-Smirnov test was used to verify 
standard normal distributional assumptions. Analysis of 





Two hundred ninety nine patients underwent robotic sur-
gery during the study period. One patient who was diag-
nosed with cervix cancer and initially planned to undergo 
robot-assisted radical surgery was converted to convention-
al laparoscopy due to mechanical failure of the robotic sys-
tem. Finally, the surgical outcomes of 298 patients were 
evaluated in this study. 
Table 1 lists the patient demographics. The median age of 
the patients was 48 years (range 24‒78 years). The median 
body mass index was 23.0 kg/m2 (range 17.0‒40.0 kg/m2). 
Fifty-four patients (18.1%) reported having at least one pri-
or abdominal-pelvic surgery. One or more medical co-mor-
bidities were reported in approximately one fourth of the 
patients (26.8%). Operative procedures included 17 myo-
mectomies (5.7%), 39 total hysterectomy with or without 
adnexectomy (13.1%), 112 staging surgeries for endometri-
al cancer (37.6%), and 130 radical hysterectomies for cervi-
cal cancer (43.6%). Ten out of 39 patients (25.6%) under-
went hysterectomy±adnexectomy due to uterine and/or 
adnexal invasion of rectal, stomach, or bladder cancer.
Surgical outcomes are shown in Table 2. The overall mean 
uterine wall was repaired with interrupted sutures of 1-Vic-
ryl or continuously with barbed suture, V-loc (Covidien, 
Dublin, Ireland). Excised myomas were morcellated or cut 
and extracted from the umbilicus after placing the specimen 
into a Lap bag (Sejong Medical, Paju, Korea). Upon com-
pletion of the procedure, the fascia of the port sites greater 
than 8 mm in diameter were closed with interrupted suture 
using 1-0 Vicryl (Ethicon, Piscataway, NJ, USA) or by an 
Endoclose suture device (Tyco Auto Suture International 
Inc., Norwalk, CT, USA). The skin at trocar sites was not 
sutured, but approximated with Steri-Strips (3M, St. Paul, 
MN, USA).
Patients who underwent a myomectomy, hysterectomy, 
or adnexectomy received only prophylactic antibiotics 30 
minutes before surgery. For those patients who underwent 
staging surgery and radical hysterectomy, antibiotics were 
used for postoperative five days. Indwelling bladder cathe-
ters were removed on postoperative day one for those who 
Table 1. Patient Demographics
Variables n=298
Age (yrs)*      48 (24–78)
BMI (kg/m2)*   23.0 (17.0–40.0)
Parity*        2 (0–7)
Patients with medical co-morbidity, n (%)      80 (26.8)
Previous abdominal-pelvic surgery history, 
  n (%)      54 (18.1)
FIGO surgical stage for endometrial 
  cancer
    Stage 1 97
    Stage 2   7
    Stage 3   8
FIGO clinical stage for cervical cancer
    Stage 1A2 18
    Stage 1B1 87
    Stage 1B2   9
    Stage 2A1   8
    Stage 2B   8
Operative procedures
    Myomectomy, n (%)      17 (5.7)
    Complex total hysterectomy± 
      adnexectomy, n (%)      39 (13.1)
    Staging surgery for endometrial cancer, 
      n (%)    112 (37.6)
    Radical hysterectomy for cervical 
      cancer, n (%)    130 (43.6)
        Type B1 modified radical 
          hysterectomy   18
        Type C2 radical hysterectomy 112
BMI, body mass index; FIGO, Federation of Gynecology and Obstetrics.
*Data are given as median (range).
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operative time was 208.5±73.9 minutes, console time was 
159.2±66.4 minutes, and docking time was 5.1±3.8 minutes. 
The mean estimated blood loss (EBL) was 184 mL. The lon-
gest console time and highest EBL were recorded after myo-
mectomy, with mean console time of 276.4 minutes and 
blood loss of 280 mL, respectively. Myomectomy was the 
latest procedure type commenced at our institution (year 
2010). The overall mean hospital stay was 8.9 days. Longest 
hospital stay was seen after radical hysterectomy (mean 
11.4±5.2 days) due to postoperative bladder catheter training. 
There was no conversion to laparotomy. Accurate measure-
ment of docking time, blood loss, and hospital stay were not 
possible for hysterectomy cases, since 25% were performed 
as a co-operation with other departments. 
Complication data are shown in Table 3 and 4. One case 
planned for radical hysterectomy was converted to laparos-
copy due to mechanical malfunction of the robotic system. 
The plan for a robotic procedure was aborted at the initial 
set-up prior to the patient’s entrance into the operating room. 
There were no intra-operative device failures that resulted 
into an unexpected conversion. The overall complication 
rate was 18.8%, including both minor and major complica-
tions. Intra-operative complications including a bladder in-
jury and a bowel content leakage during appendectomy and 
adhesiolysis occurred during radical hysterectomy and pel-
vic lymph node dissection. Three cases of vessel injury [re-
nal vein (n=1), aortal (n=1), external iliac vein (n=1)] oc-
curred during the staging and lymph node dissection for 
endometrial cancer. However, these injuries were managed 
robotically without conversion to another surgical approach. 
The common early complications occurring before postop-
erative 6 weeks were febrile events (n=6), lymphedema 
(n=4), vaginal vault bleeding in case of hysterectomy (n=5), 
voiding difficulty (n=4), peritonitis (n=4), and hemovac site 
leakage (n=5). The frequencies of late postoperative events 
were less than those in the early postoperative period. Three 
Table 2. Surgical Outcomes According to Procedure












Operative time (min) 208.5±73.9 167.5±25.7 322.6±110.2 199.1±60.4 210.0±72.7 <0.001
Console time (min) 159.2±66.4 143.0±37.7 276.4±128.3 146.2±51.8 158.6±55.2 <0.001
Docking time (min)   5.1±3.8 N/A 5.0±2.5   5.0±2.8   5.1±4.5 0.837
Estimated blood loss (mL)   184.8±183.3 N/A 280.0±254.8   175.0±151.5   161.8±153.9 0.009
Uterine weight, g   145.5±102.5   228.4±175.4 N/A 138.2±82.0 117.4±58.8 <0.001
Hospital stay, days   8.9±4.9 N/A 3.8±1.3   8.2±3.5 11.4±5.2 <0.001
EM, endometrial; N/A, not applicable.
Data are given as mean±standard deviation.
Table 3. Intraoperative and Postoperative Complications
Variable n (%)
Intraoperative complications  5 (1.7)
    Vessel injury  3 (1.0)
    Bladder injury  1 (0.3)
    Bowel content leakage during appendectomy  1 (0.3)
Early postoperative complications  43 (14.4)
    Febrile morbidity 6 
    Severe leg edema/pain 4 
    Leg weakness 2 
    Vaginal vault bleeding 5 
    Vaginal vault leakage 2 
    Vaginal vault infection 1 
    Voiding difficulty 4 
    Urinary tract infection 1 
    Hematuria 3 
    Pelvic abscess/peritonitis 4 
    Wound infection 2 
    Massive chyle ascites 1 
    Pelvic drainage catheter site leakage 5 
    Hematoma 1 
    Severe muscle strain 1 
    Drug hypersensitivity 1 
Late postoperative complications   8 (2.7)
    Leg weakness 1 
    Voiding difficulty 3
    Hydronephrosis 1
    Ureterovaginal fistula 1
    Peritonitis 1
    Wound infection 1
Clavien-Dindo classification of postoperative  
  complications
    I (no treatment) 29 (9.7)
    II (need for pharmacological treatment) 16 (5.4)
    IIIA (intervention under local anesthesia)   4 (1.4)
    IIIB (intervention under general anesthesia)   1 (0.3)
    IV (intensive care due to single or 
      multiorgan failure) 0
    V (death) 0
Overall complication rate   56 (18.8)
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paracentesis at the emergency unit. No patient experienced 
organ failure or death after surgery. When stratified accord-
ing to procedure types (Table 4), the most frequent compli-
cations greater than or equal to grade 2 in the myomectomy 
group were one case of uterine incision site hematoma, two 
cases (5.1%) of infection related morbidity in simple hys-
terectomy group, vessel injury (three cases, 2.7%) among 
the endometrial cancer staging group, which occurred dur-
ing lymph node dissection, and six cases (4.6%) of urinary 
complication in the radical hysterectomy group.
DISCUSSION
The results of this study demonstrate that robot-assisted 
laparoscopic surgery is a feasible approach in gynecology 
with acceptable complications. The da Vinci robotic system 
was approved by the United States Food and Drug Adminis-
tration in the gynecologic field in 2005, with unique charac-
teristics of wristed instruments, tremor elimination, steady 
three-dimensional visualization, and an ergonomic working 
position.6 These features may help surgeons overcome some 
of the limitations associated with conventional laparoscopic 
surgery. Although there are several studies regarding the fea-
sibility of robot-assisted laparoscopic surgery in gynecology, 
studies have mainly focused on perioperative morbidity 
with standardized classification.4,8 Since robotic surgery is in 
its infancy compared to other conventional laparoscopic or 
open abdominal approaches, continuous investigation is 
important. 
There are several studies demonstrating the feasibility and 
complications of robotic surgery using four robotic arms. 
Bedient, et al.9 reported a peri-operative complication rate 
of 16% in 40 robot-assisted laparoscopic myomectomy 
cases. In their cohort, two patients (5%) were readmitted 
because of ileal perforation, likely attributable to an electri-
cal injury, during surgery and for febrile urinary tract infec-
tion. Their postoperative complication rate was 11%, includ-
ing one pneumonia, two blood transfusions, two wound 
infections, one bowel injury, and one pelvic abscess. In this 
study, the number of myomectomies performed was about 
half than that in the study by Bedient, et al.9 Still, there was 
only one grade 2 complication of uterine hematoma, which 
needed conservative treatment with intravenous iron sup-
plementation. Another unusual complication after myomec-
tomy was a patient who complained of immobility of her 
left arm due to severe trapezoid muscle pain immediately 
patients with voiding difficulty that underwent radical hys-
terectomy were managed conservatively. Patients that had 
an infection or lymphocele were discharged after conserva-
tive management with antibiotics. No patient experienced a 
bowel obstruction, incisional hernia, or vaginal vault dehis-
cence. A patient who had neuropathy in the early postoper-
ative period, including obturator nerve and femoral cutane-
ous nerve neurapraxia, had improved after six weeks with 
rehabilitation. Most of the early and late postoperative com-
plications were spontaneously resolved by conservative 
management (grade 1 or 2). Complications greater than 
grade 3 by Clavien-Dindo classification, defined as surgical 
postoperative complications requiring surgical or radiologi-
cal intervention, occurred in 5 patients (1.7%). The most se-
vere complication (grade IIIB) occurred in one patient who 
presented with panperitonitis due to bowel perforation that 
had developed postoperatively after radical hysterectomy. 
Diagnostic laparoscopy of this patient revealed extensive 
stool soilage in the abdominal cavity, leaking from an ap-
proximately 1-cm sized laceration site on the anterior wall 
of the upper rectum. Low anterior resection with diverting 
ileostomy was proceeded via a laparotomy. Ileostomy was 
successfully repaired 3 months after low anterior resection. 
Among 4 patients with grade IIIA complications, two pa-
tients received ureteral stent insertion due to ureterovaginal 
fistula and unilateral hydronephrosis. One hemovac inser-
tion site dehiscence was treated with antibiotics and resu-
turing under local anesthesia. The last grade IIIA complica-
tion was a patient with severe chyle ascites that necessitated 
Table 4. Type of Perioperative Complications (Clavien-Dindo 
Classification ≥2) According to Treatment Method
Variable n (%)
Myomectomy (n=17)
    Uterine hematoma 1 (5.9)
Simple total hysterectomy±adnexectomy (n=39)
    Infection 2 (5.1)
Staging surgery for endometrial cancer (n=112)
    Vessel injury 3 (2.7)
    Febrile morbidity 1 (0.9)
    Pelvic cavity infection/hematoma 2 (1.8)
    Massive chyle ascites 1 (0.9)
    Pelvic drainage catheter site leakage 1 (0.9)
    Wound infection 1 (0.9)
Radical hysterectomy for cervical cancer (n=130)
    Urinary complication 6 (4.6)
    Febrile morbidity 2 (1.5)
    Panperitonitis due to bowel injury 1 (0.8)
    Wound infection 1 (0.8)
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lymphedema in 103 cases. Three cases (2.8%) were con-
verted to laparotomy in their report. Persson, et al.6 demon-
strated a peri/postoperative complication rate of 41% of in 
robotic assisted laparoscopic radical hysterectomies. Five 
patients (6%) developed vaginal cuff dehiscence, three pa-
tients had port site herniation (4%), one patient (1%) had a 
ureter stricture, and one patient (1%) experienced reversible 
partial obturator nerve palsy. In two cases, the small bowel 
was incarcerated through the opening at the site of a 15-mm 
trocar. In the current analysis, the rate of complications that 
needed pharmacological intervention (Clavien-Dindo classi-
fication ≥2) was as expected. During endometrial cancer 
staging operations, our policy is to do a full lymphadenecto-
my up to the renal vein level unless the patient is medically 
inapt for prolonged surgery. Therefore, vessel injury was the 
highest type of complications that needed intraoperative in-
tervention. During radical hysterectomy for cervical cancer, 
urinary complications were expected to be the most frequent 
events during the extensive dissection of the ureter and blad-
der. These speculations were confirmed in our data (Table 4).
In the present study, the authors used only three robotic 
arms and an assistant conventional port for all procedures. 
The overall complication rate was 18.8% and that for only 
the oncologic cases was 16.1%; complication rates in our co-
hort did not significantly deviate from other rates (6.8‒41%) 
reported in previous studies that used four robotic arms.3,6,13,14 
In addition, the intra-operative complication rate was low 
(1.7%), and all cases were continued robotically without 
after surgery. Plain radiologic X-rays showed no signs of 
bone fracture. All patients in this study had both arms 
tucked to each side, instead of placing them on arm boards, 
to avoid brachial plexus injury. Also, gel or cushion pads 
were fastened to the surgical table to support the upper 
body and shoulders. Nonetheless, severe muscle strain de-
veloped in one patient, presumably due to pressure from 
the steep Trendelenburg position. This was the only case of 
severe muscle pain after gynecologic robotic surgery at our 
institution. The authors believe that proper patient position-
ing is crucial to reducing complications in robotic surgery.
Complication rates during and after gynecologic onco-
logic surgeries are expected to be higher than that of benign 
gynecologic cases due to extensive dissection and broader 
surgical field. Veljovich, et al.10 reported operative outcomes 
of 118 robotic surgeries in gynecologic oncology. The major 
complication rate therein was 6.8%, including two vessel 
injuries, two venous thromboembolisms, two vaginal cuff 
dehiscences, one readmission for small bowel obstruction, 
and one intensive care unit admission. Two patients were 
converted to laparotomy. The first had a body mass index 
(BMI) of 49 kg/m2 and was eventually converted for lapa-
rotomic endometrial cancer staging; the second was under-
going a radical hysterectomy with extensive distortion and 
obliteration of normal avascular anatomic planes. Boggess, 
et al.12 reported an overall complication rate of 6.8% for en-
dometrial cancer staging, which included one bowel injury, 
one port site hernia, one pulmonary embolism, and one 
Table 5. Complications of Robotic Oncologic Surgeries (Literature Review and Present Study)













Boggess, et al.12 103 Staging for EM cancer    191.2 74.5 1.0   7 (6.8) 3 (2.8)
Holloway, et al.14 100 Staging for EM cancer 171 103 1.12 20 (30.8) 4 (4)
Gehrig, et al.22   49 Staging for EM cancer 189 50 1.0   6 (12.2) 0
Veljovich, et al.10 118 Staging for EM cancer 283 66.6 1.7 21 (17.8) 0
Lambaudie, et al.23   32 Staging for EM cancer, 
  RH for cervical cancer
180 100 3.0   6 (18.8) 0
Persson, et al.6   80 RH for cervical cancer 262 150 3.0 33 (41) 0
Lowe, et al.8   42 RH for cervical cancer 215 50 1.0   7 (16.8) 1 (2.4)
ElSahwi, et al.25 150 Staging for EM cancer 127 119 1.5 40 (25.8) 0
Coronado, et al.29   71 Staging for EM cancer 189 99.4 3.5 15 (21.1) 3 (2.4)
Chong, et al.26   50 RH for cervical cancer 230 55 9.6   7 (14) 0
Seror, et al.27   40 Staging for EM cancer 248 ND 6.9 10 (25) ND
Pakish, et al.28   52 Staging for EM cancer 298 68 1 11 (21.1) 2 (3.9)
Present study* 242 Staging for EM cancer, 
  RH for cervical cancer
205 168 9.8 39 (16.1) 0
EBL, estimated blood loss; EM, endometrial; RH, radical hysterectomy; ND, not defined.
*The present study indicates only oncologic cases for overall comparison.
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ports, including three robotic arms and one assistant 10-mm 
port, for all operations. In general, five to six ports were 
placed in the patients’ abdomen in order to perform robot as-
sisted laparoscopic surgery in most studies. The low number 
of trocars in our approach may have decreased the chance 
of trocar site hernia. Additionally, due to the relatively low-
er average BMI of Korean women than that of other West-
ern countries,19 it was feasible to access the upper para-aor-
tic area with only standard docking (instead of side docking). 
The other difference in postoperative complication is that 
there was no vaginal cuff dehiscence in our study. In a study 
by Kho, et al.,20 the rate of vaginal cuff dehiscence was 4.1% 
(21/510) after robotic hysterectomies. The cause of higher 
incidences of vaginal cuff dehiscence in laparoscopic and ro-
botic hysterectomies is unknown, and multiple factors may 
be involved.21 Thermal effect, racial difference, the size of 
genital organs, smoking, and high BMI are suspected, al-
though results inconclusive. Meanwhile, suture method and 
type of sutures do not seem to promote any increase in vault 
dehiscence, as shown in a review by Drudi, et al.24 In their 
study, postoperative chemotherapy and/or brachytherapy 
were also risk factors for dehiscence, such that those who 
received adjuvant treatment had a higher rate thereof, com-
pared to patients who did not (3% vs. 0.4%, respectively). In 
our cohort of oncologic cases, 56 out of 281 patients (19.9%) 
received adjuvant therapy of chemotherapy, radiotherapy, or 
both; however, no case of vaginal dehiscence requiring repair 
occurred. It is our routine practice to educate patients to re-
frain from coital activity and tub baths at least 2 months after 
the surgery. Also, only 1.9% of patients were smokers. Final-
ly, there were no embolic events in this cohort.
The limitation of this study is the lack of comparisons 
with conventional laparoscopy and laparotomy. Thus, it is 
difficult to make definitive conclusions based on our find-
ings, and further randomized prospective studies in large 
population settings are crucial to uncovering significant clin-
ical implications. Despite this weakness, the strength of our 
study is that we evaluated data from a high volume institu-
tion and thereby provides a greater perspective on the kinds 
of perioperative complications that could potentially arise 
during robot-assisted laparoscopic procedures. Also, modi-
fication of the surgical procedure, such as using only three 
robotic arms, may provide a reference to other surgeons who 
perform gynecologic surgeries in a similar setting. Although 
the reason for using only three arms was originally due to 
cost issues, this method has become our current practice 
without significant limitations. 
conversion to laparoscopy or an open method. Table 5 sum-
marizes data from a review of published robot-assisted lap-
aroscopic studies, and shows that the complication rates of 
our cohort are comparable to previous reports. In this study, 
one patient was converted to a laparoscopic radical hyster-
ectomy due to mechanical failure. The patient had her pro-
cedures aborted secondary to system failure at the initial set-
up prior to the patient’s entrance into the operating room. 
There were no intra-operative device failures that resulted 
in a case conversion. Technical errors that could potentially 
handicap a surgeon have not occured in our institution so 
far. In previous studies, the mean recoverable and non-re-
coverable fault rates per procedure were reported to be 0.21 
and 0.05, respectively, since the last computer system up-
grade.15 However, one external iliac vein injury during pel-
vic lymph node dissection occurred by a small tear in the 
elastic sheath of the robotic instrument, which seemed to 
have lacerated the vein when the instrument head brushed 
near the vessel. Accordingly, regular surveillance on the 
mechanical and technical status of the robotic system is 
crucial to prevent unexpected complications during surgical 
procedures.
The data from this cohort is different from other previous 
studies in regards to certain types of complications. One of 
them is that there was no trocar site hernia among our cases. 
Trocar site hernia is a rare but serious complication when 
bowel strangulation and infection occurs. One of the known 
risk is when large ports (10 mm in diameter or larger) are 
used; trocar site hernia is uncommon for ports less than 10 
mm in diameter, ranging from 0 to 1.2%. Nevertheless, 
Seamon, et al.16 reported a case of bowel herniation through 
an 8-mm robotic port site, and Persson, et al.6 also observed 
port site hernia in three of 80 cases of robotic radical hys-
terectomy. In contrast, a recent article that used bladeless 
12-mm and 8-mm trocars reported no hernias and only one 
port site dehiscence, recommending that fascial closure is 
unnecessary when using bladeless trocars.17 In our cohort, 
about 70% of patients underwent fascial closure using En-
doclose suture device to seal incisions that were larger than 
8 mm. This device allows for the approximation of tissues 
and percutaneous suturing of port sites laparoscopically. The 
differences in port site herniation might also be explained by 
the low BMI of our patients, compared to other reports of 
Caucasian patients (median BMI of 23.0 kg/m2). Obese pa-
tients have a greater risk of developing hernias at an inci-
sion site due to the larger preperitoneal space and elevated 
intra-abdominal pressure.18 Furthermore, we only used four 
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Shalhav AL, et al. Da Vinci robot error and failure rates: single in-
stitution experience on a single three-arm robot unit of more than 
700 consecutive robot-assisted laparoscopic radical prostatecto-
mies. J Endourol 2007;21:1341-4.
16. Seamon LG, Backes F, Resnick K, Cohn DE. Robotic trocar site 
small bowel evisceration after gynecologic cancer surgery. Obstet 
Gynecol 2008;112(2 Pt 2):462-4.
17. Boone JD, Fauci JM, Barr ES, Estes JM, Bevis KS. Incidence of 
port site hernias and/or dehiscence in robotic-assisted procedures in 
gynecologic oncology patients. Gynecol Oncol 2013;131:123-6.
18. Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M. Trocar site 
hernia. Arch Surg 2004;139:1248-56.
19. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Body-
mass index and mortality in Korean men and women. N Engl J 
Med 2006;355:779-87.
20. Kho RM, Akl MN, Cornella JL, Magtibay PM, Wechter ME, 
Magrina JF. Incidence and characteristics of patients with vaginal 
cuff dehiscence after robotic procedures. Obstet Gynecol 2009;114 
(2 Pt 1):231-5.
21. Kim MJ, Kim S, Bae HS, Lee JK, Lee NW, Song JY. Evaluation 
of risk factors of vaginal cuff dehiscence after hysterectomy. Ob-
stet Gynecol Sci 2014;57:136-43.
22. Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Bog-
gess JF. What is the optimal minimally invasive surgical proce-
dure for endometrial cancer staging in the obese and morbidly 
obese woman? Gynecol Oncol 2008;111:41-5.
23. Lambaudie E, Houvenaeghel G, Walz J, Bannier M, Buttarelli M, 
Gurriet B, et al. Robot-assisted laparoscopy in gynecologic oncol-
ogy. Surg Endosc 2008;22:2743-7.
24. Drudi L, Press JZ, Lau S, Gotlieb R, How J, Eniu I, et al. Vaginal 
vault dehiscence after robotic hysterectomy for gynecologic can-
cers: search for risk factors and literature review. Int J Gynecol 
Cancer 2013;23:943-50.
25. ElSahwi KS, Hooper C, De Leon MC, Gallo TN, Ratner E, Silasi 
DA, et al. Comparison between 155 cases of robotic vs. 150 cases 
of open surgical staging for endometrial cancer. Gynecol Oncol 
2012;124:260-4.
26. Chong GO, Lee YH, Hong DG, Cho YL, Park IS, Lee YS. Robot 
versus laparoscopic nerve-sparing radical hysterectomy for cervi-
cal cancer: a comparison of the intraoperative and perioperative 
results of a single surgeon’s initial experience. Int J Gynecol Can-
cer 2013;23:1145-9.
27. Seror J, Bats AS, Huchon C, Bensaïd C, Douay-Hauser N, Lécuru 
F. Laparoscopy vs robotics in surgical management of endometrial 
cancer: comparison of intraoperative and postoperative complica-
tions. J Minim Invasive Gynecol 2014;21:120-5.
28. Pakish J, Soliman PT, Frumovitz M, Westin SN, Schmeler KM, 
Reis RD, et al. A comparison of extraperitoneal versus transperito-
neal laparoscopic or robotic para-aortic lymphadenectomy for stag-
ing of endometrial carcinoma. Gynecol Oncol 2014;132:366-71.
29. Coronado PJ, Herraiz MA, Magrina JF, Fasero M, Vidart JA. 
Comparison of perioperative outcomes and cost of robotic-assist-
ed laparoscopy, laparoscopy and laparotomy for endometrial can-
cer. Eur J Obstet Gynecol Reprod Biol 2012;165:289-94.
In conclusion, three-armed robot-assisted laparoscopic 
surgery in gynecology is feasible with few major complica-
tions. The use of objective grading tools may be helpful to 
classifying perioperative complications with better stan-
dardization. In addition, surgeons should be vigilant on the 
potential risks of mechanical failure of the robotic system 
to prevent further unexpected complications.
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